Danaher (DHR) July weekly 245 straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
Danaher (DHR) PT Raised to $300 at Argus
July 24, 2024 8:57 AM EDTArgus analyst John Eade raised the price target on Danaher (NYSE: DHR) to $300.00 while maintaining a Buy rating.
The analyst comments "Our BUY rating on Danaher Corp. (NYSE: DHR) reflects our view that Danaher is well... More
Danaher (DHR) PT Raised to $275 at BofA Securities
July 24, 2024 5:24 AM EDTBofA Securities analyst Michael Ryskin raised the price target on Danaher (NYSE: DHR) to $275.00 (from $270.00) while maintaining a Neutral rating.
The analyst comments "Bioprocess market dynamics improved in the qtr, with most excess inventory having worked through the system and customers returning to normal... More
Danaher (DHR) PT Raised to $275 at Evercore ISI
July 23, 2024 12:02 PM EDTEvercore ISI analyst Vijay Kumar raised the price target on Danaher (NYSE: DHR) to $275.00 (from $260.00) while maintaining a Outperform rating.
The analyst comments "Thesis Update: Relative to the questions / fears heading into 1Q print, we thought DHR checked all the boxes and the results reaffirmed the normalization thesis. The 3 most recent data points in LST have been mixed / negative (RGEN mgmt. change, A Guide cut & last weeks SRT Guide cut), which made the DHR print topical. Overall results came in slight better vs Guide (- LSD core declines vs -MSD Guide), with the... More
